Blog

CFDA allows for drug self-inspections

In July, China’s Food and Drug Administration (CFDA) allowed self-inspections to occur for imported and local drugs. Although CFDA is allowing self-inspections for drugs, it will also be conducting random on-site inspections upon the reports that companies give them....

read more

Caldwell highlighted in HBA’s newsletter

The Health Businesswomen’s Association (HBA) interviews Diana Caldwell, President and CEO of Pearl Pathways. HBA has been around for four decades and is focused on connecting businesswomen through sharing career information. HBA’s interview was performed on July 20th,...

read more

Indiana CTSI event now open for those to register

The 7th annual meeting of the Indiana Clinical and Translational Sciences Institute will be handing out the second Watanabe Prize to Carl H. June, M.D. This year’s event will be held on September 11th and will not only be recognizing the winner of the prize, but other...

read more

5 fantastic years of business for Pearl Pathways

Pearl Pathways is celebrating 5 years of being in business. We are excited to celebrate these fantastic years and want you to join us! Appetizers and refreshments will be served throughout the evening. When: August 6th, 2015 Time: 4:30pm-7:00pm Where: 29 E McCarty...

read more

Can clinical trials really “fail”?

Every so often, clinical tries are said to ‘fail’, but can the trial actually fail? According to John Lechleiter, President and CEO of Eli Lilly and Company, “a clinical trial is a failure only if we can’t learn from it.” He believes that no matter how a clinical...

read more